Data / Drug companies / Safeway
Safeway: 382 products in the FDA NDC directory, labeler code 21130
Safeway (labeler code 21130) lists 382 products in the FDA National Drug Code Directory, covering 151 finished drugs by generic name. By type: 382 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 21, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 21130
- Products in commercial distribution
- 382
- Packages
- 558
- Finished drugs by generic name
- 151
- Prescription products
- 0
- Over the counter products
- 382
- Flagged as original packager
- 338 of 338 products that carry the flag
- Started marketing in the last 12 months
- 29
- Products with a marketing end date set
- 25
- Earliest marketing start
- August 25, 1981
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 235 | 61.5% |
| Generic drugs (ANDA) | 136 | 35.6% |
| New drug applications (NDA) | 6 | 1.6% |
| Other unapproved drugs | 3 | 0.8% |
| Unapproved homeopathic products | 2 | 0.5% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 382 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 58 | 15.2% |
| Liquid | 35 | 9.2% |
| Tablet, film coated | 29 | 7.6% |
| Tablet, chewable | 28 | 7.3% |
| Solution | 24 | 6.3% |
| Cream | 21 | 5.5% |
| Capsule, liquid filled | 20 | 5.2% |
| Suspension | 13 | 3.4% |
| Lotion | 12 | 3.1% |
| Spray | 12 | 3.1% |
| Tablet, coated | 10 | 2.6% |
| Ointment | 10 | 2.6% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Womens Laxative | 21130-552 | Tablet | Over the counter monograph drugs | October 21, 2026 |
| Daytime cold and flu relief | 21130-638 | Solution | Over the counter monograph drugs | September 30, 2026 |
| Nicotine | 21130-772 | Lozenge | Generic drugs (ANDA) | September 10, 2026 |
| Tussin | 21130-454 | Solution | Over the counter monograph drugs | July 15, 2026 |
| Minoxidil 5% (for men) | 21130-208 | Aerosol, foam | Generic drugs (ANDA) | July 3, 2026 |
| Cold and flu relief | 21130-603 | Solution | Over the counter monograph drugs | June 10, 2026 |
| Cough dm | 21130-538 | Suspension | Generic drugs (ANDA) | May 4, 2026 |
| Cold and flu relief | 21130-436 | Solution | Over the counter monograph drugs | May 4, 2026 |
| Tioconazole 1 | 21130-781 | Ointment | Generic drugs (ANDA) | May 1, 2026 |
| Omeprazole | 21130-783 | Capsule, delayed release | Generic drugs (ANDA) | April 27, 2026 |
| Loratadine 10mg | 21130-932 | Tablet | Over the counter monograph drugs | April 18, 2026 |
| Miconazole 1 | 21130-929 | Kit | Generic drugs (ANDA) | April 15, 2026 |
| Nighttime Cold and Flu | 21130-951 | Liquid | Over the counter monograph drugs | April 11, 2026 |
| Daytime Cold and Flu | 21130-947 | Liquid | Over the counter monograph drugs | April 11, 2026 |
| Childrens Pain Relief Dye free | 21130-910 | Suspension | Over the counter monograph drugs | April 11, 2026 |
| Miconazole 7 | 21130-696 | Cream | Generic drugs (ANDA) | March 6, 2026 |
| Clearlax | 21130-637 | Powder, for solution | Generic drugs (ANDA) | March 6, 2026 |
| Nasal decongestant | 21130-837 | Spray | Over the counter monograph drugs | February 27, 2026 |
| Signature care sore throat cherry flavor | 21130-196 | Spray | Over the counter monograph drugs | February 6, 2026 |
| SIGNATURE CARE Ultra Strength Stomach | 21130-193 | Suspension | Over the counter monograph drugs | February 2, 2026 |
| SIGNATURE CARE Regular Strength | 21130-182 | Suspension | Over the counter monograph drugs | February 2, 2026 |
| Signature Select Advanced Hand Sanitizer | 21130-077 | Solution | Over the counter monograph drugs | January 26, 2026 |
| Signature Select Advanced Hand Sanitizer with Aloe Vera | 21130-066 | Solution | Over the counter monograph drugs | January 26, 2026 |
| SIGNATURE CARE Childrens Multi Symptom Cold | 21130-162 | Solution | Over the counter monograph drugs | January 16, 2026 |
| Aspirin 325 mg | 21130-758 | Tablet, coated | Over the counter monograph drugs | January 5, 2026 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.